Fluoroquinolone resistant bacteria in nosocomial UTI

Tropical Doctor

Volumn 28, Issue 4, 1998, Pages 250-251

  Bhat, K Gopalkrishna ^a   Ninan, Rebu ^a   Mallya, Srikara ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN;

ANTIBIOTIC RESISTANCE; CROSS INFECTION; HUMAN; INCIDENCE; INDIA; LETTER; URINARY TRACT INFECTION;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; HUMANS; INCIDENCE; INDIA; URINARY TRACT INFECTIONS;

EID: 0032186237     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1177/004947559802800433     Document Type: Letter

References (4)

1. Coronado VG, Edwards JR, Culver DH, Gaynes RP. Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol, 1995; 16: 71-5
2. Lennete EH, Balows A, Hausler WJ Jr, Shadomy HJ, eds. Manual of Clinical Microbiology. Washington: American Society for Microbiology, 1985
3. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Test, 4th edn (approved standard M2–A4, 1990). Villanova, Pa: NCCLS, 1990
4. Ringertz S, Bullete B, Karlsson I, Ohman G, Gedebon M, Kronvall G. Antibiotic susceptibility of Escherichia coli isolates from inpatients with urinary tract infections in hospitals in Addis Ababa and Stockholm. Bull WHO, 1990; 68: 61-8